Revenue: The sum of all revenue fields included for a company's operating activities.
ARS Pharmaceuticals, Inc. (SPRY) had Revenue of $33.66M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$33.66M |
$-62.38M |
|
$12.85M |
|
$20.81M |
|
$95.12M |
|
$-61.47M |
|
$-0.87M |
|
$-62.34M |
|
$-62.34M |
|
$-62.34M |
|
$-62.34M |
|
$-62.34M |
|
$-62.34M |
|
$-61.47M |
|
$-61.70M |
|
99.31M |
|
99.31M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$211.51M |
|
$2.08M |
|
$37.98M |
|
$249.50M |
|
$60.86M |
|
$171.60M |
|
$176.12M |
|
$236.98M |
|
$12.51M |
|
$-1.39M |
|
$12.51M |
|
99.44M |
|
| Cash Flow Statement Financials | |
$-105.87M |
|
$69.36M |
|
$3.36M |
|
$41.32M |
|
$8.16M |
|
$-33.15M |
|
$19.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.48 |
|
-- |
|
-- |
|
0.93 |
|
13.72 |
|
61.83% |
|
-182.62% |
|
-182.62% |
|
-- |
|
-185.21% |
|
-185.34% |
|
$-105.87M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
1.10 |
|
0.72 |
|
125.25 |
|
-498.23% |
|
4491.26% |
|
-24.99% |
|
-33.86% |
|
$0.13 |
|
$-1.07 |
|
$-1.07 |
|